ACER THERAPEUTICS
Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare, and life-threatening diseases with critical unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errors of metabolism, including urea cycle disorde... rs (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO™ (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.
ACER THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.acertx.com
Total Employee:
11+
Status:
Active
Total Funding:
74.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Athenex
Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-19 | Opexa Therapeutics | Opexa Therapeutics acquired by Acer Therapeutics | N/A |
Investors List
SWK Holdings
SWK Holdings investment in Post-IPO Debt - Acer Therapeutics
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
Key Employee Changes
Official Site Inspections
http://www.acertx.com Semrush global rank: 8.8 M Semrush visits lastest month: 254
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
